The Texas A&M University System

Intervet Inc.

Schering-plough Animal Health Corporation

Kangwon University-Industry Cooperation Foundation

Insoo Choi

Mark D Cochran

Barbara J Winslow

Ellen W Collisson

Hakju Lee

Seongbeom Kim

Seunghwan Lee

Stephen Hash

Hyemin Jung

Jungmin Choi

Provided is a manufacturing method of an electrode for an electrochemical reaction, which is capable of minimizing a loss of a metal precursor and simultaneously reducing a manufacturing time. An embodiment of the present invention provides a manufacturing method of an electrode for an electrochemical reaction, which includes a process of forming a metal thin-film on a substrate disposed in a reactor and in which the metal thin-film is formed as a metal precursor gas derived from a metal precursor is thermally decomposed by a CO-laser.

Manufacturing method of electrode for electrochemical reaction, electrode for electrochemical reaction manufactured therefrom and reverse electrodialysis electric generating device

The present invention provides isolated and purified DNA encoding feline CD80 (B7-1) ligand, feline CD86 (B7-2) ligand, feline CD28 receptor, or feline CTLA-4 (CD152) receptor, as well as vectors comprising nucleic acid encoding feline CD80, feline CD86, feline CD28, or feline CTLA-4. The present invention provides a host cells transformed with CD80-encoding vectors, CD86-encoding vectors, CD28-encoding vectors, or CTLA-4-encoding vectors. The invention provides polypeptides encoded by the nucleic acid of feline CD80, feline CD86, feline CD28, or feline CTLA-4. The present invention provides a vaccine comprising an effective amount of polypeptides encoded by the nucleic acid of feline CD80, feline CD86, feline CD28, or feline CTLA-4. The present invention also provides vaccines which further comprise immunogens derived from pathogens. The invention provides for vaccines capable of enhancing an immune response. The invention also provides for vaccines capable of suppressing and immune response.

Feline CTLA-4 nucleic acid and polypeptides

The present invention involves a recombinant virus which comprises at least one foreign nucleic acid inserted within a non-essential region of the viral genome of a virus, wherein each such foreign nucleic acid encodes a protein. The protein which is encoded is selected from the groups consisting of a feline CD28 protein or an immunogenic portion thereof, a feline cD80 protein or an immunogenic portion thereof, a feline CD86 protein or an immunogenic portion thereof, or a feline CTLA-4 protein or an immunogenic portion thereof. The protein is capable of being expressed when the recombinant virus is introduced into an appropiate host. The present invention also involves a recombinant virus further comprising a foreign nucleic acid encoding an immunogen derived from a pathogen. The present invention also comprises recombinant viruses which are capable of enhancing an immune response in a feline. The present invention also comprises recombinant viruses which are capable of suppressing an immune respons in a feline.

Recombinant virus expressing foreign DNA encoding feline CD86 and uses thereof

Growing community of inventors

Seoul, South Korea

Insoo Choi